UNSPSC 51191567: Sulosemide

This classification denotes a diuretic with the molecular formula C17H16N2O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CY351D07GJ, chemically known as benzenesulfonic acid, 2-(furfurylamino)-4-phenoxy-5-sulfanoyl- but generally known as sulosemide, which bears US NIH Compound Identifier 213033. European Medicines Agency schedules Sulosemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10755MIG.

UNSPSC 51191567 Sulosemide is a Commodity code that in practice covers chemical supply for municipal water treatment operations and generic pharmaceutical products for state and local health facilities. The recent solicitations under this code show divergent scope — the City of Meriden's IFB for sodium bisulfite procurement targets a single chemical input for wastewater treatment, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP seeks manufacturers of generic multi-source pharmaceuticals and over-the-counter products for distribution across state and local government health facilities in Minnesota, Oregon, and participating jurisdictions. The issuing bodies reflect that mix: municipalities procuring specific industrial chemicals for water management, and state-level cooperative purchasing entities aggregating pharmaceutical supply across multi-state member networks. Municipal water authorities and state health procurement offices are the primary buyers under this code.

Geographic activity centers on the upper Midwest and Northeast, with Minnesota's MMCAP cooperative purchasing (administered by the Minnesota Department of Administration's Office of State Procurement) and Connecticut municipal procurement as recent anchors. The City of Meriden's sodium bisulfite IFB (Solicitation B027-15, due July 29, 2026) represents municipal chemical procurement, while MMCAP's RFP for generic pharmaceuticals and OTC products (Solicitation S1070000015802, due March 26, 2026, with awarded vendors effective July 1, 2026) covers multi-state institutional health supply. The MMCAP procurement requires cGMP and DSCSA compliance, establishes pricing through EDI-enabled wholesaler chargeback systems, and evaluates vendors primarily on price competitiveness (75 percent weighting) alongside administrative compliance and electronic data capability. Performance penalties of $200 to $1,500 per violation apply for late reporting, missed onboarding, or trade-class denials. Both opportunities require comprehensive insurance and performance/payment bonding.